| Product NDC: | 0527-0586 |
| Proprietary Name: | Dicyclomine Hydrochloride |
| Non Proprietary Name: | Dicyclomine Hydrochloride |
| Active Ingredient(s): | 10 mg/1 & nbsp; Dicyclomine Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0527-0586 |
| Labeler Name: | Lannett Company, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA084285 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19740930 |
| Package NDC: | 0527-0586-05 |
| Package Description: | 500 CAPSULE in 1 BOTTLE (0527-0586-05) |
| NDC Code | 0527-0586-05 |
| Proprietary Name | Dicyclomine Hydrochloride |
| Package Description | 500 CAPSULE in 1 BOTTLE (0527-0586-05) |
| Product NDC | 0527-0586 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Dicyclomine Hydrochloride |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 19740930 |
| Marketing Category Name | ANDA |
| Labeler Name | Lannett Company, Inc. |
| Substance Name | DICYCLOMINE HYDROCHLORIDE |
| Strength Number | 10 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Anticholinergic [EPC],Cholinergic Antagonists [MoA] |